Menu
Recruiting NCT03427996

Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice

Observational Atherosclerosis, Coronary Coronary Stenosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Rotational atherectomy.
Who it may be relevant to
Registry conditions: Atherosclerosis, Coronary, Coronary Stenosis. Basic parameters: from 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study

Overview

This study evaluates the effectiveness and safety rotational atherectomy in routine clinical practice.

Interventions

  • Procedure Rotational atherectomy
    Percutaneous coronary intervention with rotational atherectomy

Primary outcome measures

  • Target vessel failure (TVF) [Time frame: 1 year]
Secondary outcome measures (10)
  • All death [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Cardiac death [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Myocardial infarction [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Composite of death or myocardial infarction [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Composite of cardiac death or myocardial infarction [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Target-lesion revascularization (TLR) [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Target-vessel revascularization (TVR) [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Stent thrombosis [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Stroke [Time frame: 1-,6-, and 12-months, and 3-,5-years]
  • Procedural success [Time frame: 7 days]

Eligibility criteria

Inclusion criteria

  • Patients ≥ 19 years old
  • Patients who received rotational atherectomy
  • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion criteria

  • Life expectancy <1y

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

South Korea · 8 centers
  • Soon Chun Hyang University Hospital Bucheon — Bucheon-si
  • Daegu Catholic University Medical Center — Daegu
  • Chungnam National University Hospital — Daejeon
  • The Catholic University of Korea, Daejeon ST. Mary's Hospital — Daejeon
  • Chonnam National University Hospital — Gwangju
  • Inje University Pusan Paik Hospital — Pusan
  • Bundang CHA Hospital — Seongnam
  • Asan Medical Center — Seoul

Identifiers

NCT: NCT03427996 · AMCCV2018-02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗